News

EDS Interviews the CEO and President of PanGenex Corporation (PGXC); Issues Strong Buy Recommendation

TAMPA, Fla.-(Business Wire)-October 2, 2008 - PanGenex Corporation (Pink Sheets: PGXC) announced today that CEO and President, Jeff Roman, is featured in a broad scope text interview by Eric David Finance, Inc. (EDS). EDS, a Plainsboro, NJ-based Financial Marketing Consulting Firm, specializes in the Micro-Cap industry. The interview is an in depth discussion on how PanGenex Corporation intends to capitalize on its growth prospects in the $70 billion dollar nutraceutical and dietary supplement industry. The full text of Mr. Roman's interview is available on the Eric David Website on the following link: http://www.ericdavid.com/newsletter/mailer/PGXC093008.html.

Steven J. Weiss, President of EDS, stated that “PanGenex Corporation presents a unique, aggressive entry into a market where originality and strength determine longevity. The PanGenex product line has all the earmarks of a major competitor in the natural supplement industry. Current shares outstanding of 41 million, a very low public float of 7.7 million shares, minimal long term debt and a revenue projection of $10 million dollars for fiscal 2009 show tremendous upside potential to these PanGenex shares which are much undervalued at their current price of $.065.”

About Eric David Finance, Inc.

Specializing in Investor Relations, Eric David Finance, Inc. is a financial management, marketing and consulting firm that seeks to better publicize companies with unique products and services and whose stock is undervalued in relation to their long term earnings potential.

About PanGenex Corporation:

PanGenex is a publicly traded corporation (PINK SHEETS: PGXC) and pursues business opportunities in the $70 billion dollar nutraceutical and dietary supplement industry. With a focus on the cardiovascular health segment, PanGenex develops and markets sector leading, patented or patent pending, condition specific nutraceuticals and topical over-the-counter (OTC) drugs and personal care products. Each product is scientifically formulated to address specific health conditions. Many of our products contain the purest grade of nutraceutical components available anywhere without a prescription. PanGenex markets products through healthcare practitioners, retail establishments and the internet on websites such as www.PanGenex.com, www.Calgenex.com and www.HeartHealthyWorld.com.

Disclaimer:

CAUTIONARY STATEMENT ABOUT FORWARD-LOOKING STATEMENTS

This press release contains "forward-looking statements," which are statements related to future, not past, events. In this context, the forward-looking statements often include statements regarding our goals, plans, projections and guidance regarding our financial position, results of operations, market position, pending and potential future acquisitions and business strategy, and often contain words such as "expects," "anticipates," "intends," "plans," "believes," "seeks" or "will." Any such forward-looking statements are not assurances of future performance and involve risks and uncertainties that may cause results to differ materially from those set forth in the statements. These risks and uncertainties include, among other things, (a) general economic and business conditions, (b) the level of strategic partner incentives, (c) the future regulatory environment, (d) our cost of financing, (e) our ability to complete acquisitions and dispositions and the risks associated therewith, and (f) our ability to retain key personnel. These factors, as well as additional factors, could affect our forward-looking statements. We urge you to carefully consider this information. We undertake no duty to update our forward-looking statements, including our earnings outlook. The statements in this press release have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.

Send this news item to a friend.

Print This Page